Canada: Dissolving A Poison Pill: "When, Not If" Still The Standard In Canadian Take-Over Bids

When HudBay Minerals launched an unsolicited take-over bid for Augusta Resource Corporation, the British Columbia Securities Commission (BCSC) said the Augusta poison pill should go, but only after giving the board of Augusta considerable additional time. Reaffirming the current state of the law in Canada, the BCSC indicated that it is still a matter of "when, not if" a poison pill must go.

On June 27, 2014, the BCSC released the reasons for its decision of May 2, 2014, in which it declined to immediately cease-trade a poison pill implemented by Augusta, but determined that it would cease-trade the pill 74 days later, if, among other things, HudBay's hostile take-over bid for the shares of Augusta remained open for a further 75 days. The reasons were widely anticipated by the legal community for insight into whether the proposals of the Canadian Securities Administrators (CSA) to reform the poison pill regime had influenced the BCSC's decision – as the BCSC had allowed the pill to remain in place for an unusually long period of 156 days. As it turns out, notwithstanding that the BCSC was "mindful of these proposals and the issues raised by them", the BCSC "elected not to follow the changes in policy" reflected in such proposals.

The Facts

Between 2010 and early 2013, HudBay and Augusta engaged in a number of discussions regarding potential transactions between them. During this time, through a combination of open market transactions and private placements with Augusta HudBay acquired 15% of the outstanding common shares of Augusta.

In response to this accumulation of shares, on April 18, 2013, the board of directors of Augusta adopted the pill, with an unusually low triggering threshold of 15%. HudBay was grandfathered under the pill, but any further acquisition of shares by HudBay would trigger the pill. Augusta's shareholders ratified the pill on October 17, 2013.

On February 9, 2014, HudBay announced its bid for Augusta. The bid was conditional on, among other things, a minimum tender condition and the pill being cease-traded, waived or invalidated. The board of Augusta recommended that shareholders reject the bid, noting that a group of shareholders representing 33% of the outstanding shares would not tender to the bid.

HudBay extended the bid twice, resulting in a bid expiry date of May 5, 2014. On April 8, 2014, Augusta made the decision to advance the date of a shareholder meeting called to approve continuation of the pill from May 9, 2014 to May 2, 2014 (i.e., so that shareholder approval of the continuation of the pill could be sought before the bid expired). On April 14, 2014, HudBay applied to the BCSC to have the pill cease-traded. At the meeting held on May 2, 2014, shareholders of Augusta approved the continuation of the pill.

The Decision

On May 2, 2014, the BCSC decided that if HudBay extended the bid to expire no earlier than July 16, 2014, and provided a ten-day extension of the bid if HudBay took up any shares under the bid, the BCSC would issue an order cease-trading the pill on July 15, 2014, unless Augusta issued and filed with the BCSC a news release by July 14, 2014, confirming that it had terminated the pill.

In its analysis, the BCSC considered the principles established in the Icahn Partners LP decision with respect to the public interest in relation to the adoption of poison pills as a defensive take-over bid tactic, specifically that:

  • each shareholder of a target should be allowed to decide whether or not to accept or reject a bid;
  • the board of a target has a fiduciary duty to act in the best interest of the target;
  • pills are not contrary to the public interest when used to buy time for a target to respond appropriately to the bid and they are acceptable only as a temporary defence; and
  • take-over bids are fact-specific so the relevance of the factors will vary with each case.

The BCSC also took the opportunity to reconcile apparently diverging decisions to categorically affirm that poison pills are temporary – it is a question of when, not if, a pill must go. On this basis, the BCSC addressed the question of when the Augusta pill should be cease-traded by referring to the list of non-exhaustive factors set out in the decision of Royal Host Real Estate Investment Trust. Emphasizing that each case is fact-specific, the BCSC focused on the following five factors:

  • the length of time that Augusta had already had to run a process aimed at identifying a superior transaction to the bid;
  • the likelihood of the Augusta board being able to find a superior transaction;
  • whether the bid was coercive, taking into account the waiver of the minimum tender condition;
  • the vote by Augusta shareholders to approve continuation of the pill; and
  • the likelihood that HudBay would extend its bid, if the pill were cease-traded immediately or at a specified date in the future.

The BCSC ultimately concluded that, while there were factors in support of issuing an immediate cease-trade of the pill, such factors were ultimately outweighed by the Augusta shareholder vote in favour of maintaining the pill (the context of which was carefully analyzed by the BCSC and given considerable weight in this circumstance), and the likelihood of extension of the bid by HudBay.


On June 23, 2014, prior to the release of the BCSC's reasons, Augusta and HudBay announced that they had entered into a support agreement in respect of a friendly transaction. The agreement was a result of an increase in consideration by HudBay.

The authors would like to thank Maria Valdivieso for her assistance in preparing this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
8 Nov 2016, Seminar, Ottawa, Canada

The prospect of an internal investigation raises many thorny issues. This presentation will canvass some of the potential triggering events, and discuss how to structure an investigation, retain forensic assistance and manage the inevitable ethical issues that will arise.

22 Nov 2016, Seminar, Ottawa, Canada

From the boardroom to the shop floor, effective organizations recognize the value of having a diverse workplace. This presentation will explore effective strategies to promote diversity, defeat bias and encourage a broader community outlook.

7 Dec 2016, Seminar, Ottawa, Canada

Staying local but going global presents its challenges. Gowling WLG lawyers offer an international roundtable on doing business in the U.K., France, Germany, China and Russia. This three-hour session will videoconference in lawyers from around the world to discuss business and intellectual property hurdles.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.